Nephrolithiasis-associated bone disease

Pathogenesis and treatment options

Khashayar Sakhaee, Naim M. Maalouf, Rajiv Kumar, Andreas Pasch, Orson W. Moe

Research output: Contribution to journalArticle

87 Citations (Scopus)

Abstract

Nephrolithiasis remains a formidable health problem in the United States and worldwide. A very important but underaddressed area in nephrolithiasis is the accompanying bone disease. Epidemiologic studies have shown that osteoporotic fractures occur more frequently in patients with nephrolithiasis than in the general population. Decreased bone mineral density and defects in bone remodeling are commonly encountered in patients with calcium nephrolithiasis. The pathophysiologic connection of bone defects to kidney stones is unknown. Hypercalciuria and hypocitraturia are two important risk factors for stone disease, and treatments with thiazide diuretics and alkali, respectively, have been shown to be useful in preventing stone recurrence in small prospective trials. However, no studies have examined the efficacy of these agents or other therapies in preventing continued bone loss in calcium stone formers. This manuscript reviews the epidemiology, pathophysiology, and potential treatments of bone disease in patients with nephrolithiasis.

Original languageEnglish (US)
Pages (from-to)393-403
Number of pages11
JournalKidney International
Volume79
Issue number4
DOIs
StatePublished - Feb 2011

Fingerprint

Nephrolithiasis
Bone Diseases
Calcium
Sodium Chloride Symporter Inhibitors
Therapeutics
Hypercalciuria
Bone and Bones
Osteoporotic Fractures
Kidney Calculi
Bone Remodeling
Alkalies
Bone Density
Epidemiologic Studies
Epidemiology
Recurrence
Health
Population

Keywords

  • bone disease
  • citrate
  • kidney stone
  • nephrolithiasis
  • thiazide

ASJC Scopus subject areas

  • Nephrology

Cite this

Nephrolithiasis-associated bone disease : Pathogenesis and treatment options. / Sakhaee, Khashayar; Maalouf, Naim M.; Kumar, Rajiv; Pasch, Andreas; Moe, Orson W.

In: Kidney International, Vol. 79, No. 4, 02.2011, p. 393-403.

Research output: Contribution to journalArticle

@article{1731594a409a49f1a5496786d3a26167,
title = "Nephrolithiasis-associated bone disease: Pathogenesis and treatment options",
abstract = "Nephrolithiasis remains a formidable health problem in the United States and worldwide. A very important but underaddressed area in nephrolithiasis is the accompanying bone disease. Epidemiologic studies have shown that osteoporotic fractures occur more frequently in patients with nephrolithiasis than in the general population. Decreased bone mineral density and defects in bone remodeling are commonly encountered in patients with calcium nephrolithiasis. The pathophysiologic connection of bone defects to kidney stones is unknown. Hypercalciuria and hypocitraturia are two important risk factors for stone disease, and treatments with thiazide diuretics and alkali, respectively, have been shown to be useful in preventing stone recurrence in small prospective trials. However, no studies have examined the efficacy of these agents or other therapies in preventing continued bone loss in calcium stone formers. This manuscript reviews the epidemiology, pathophysiology, and potential treatments of bone disease in patients with nephrolithiasis.",
keywords = "bone disease, citrate, kidney stone, nephrolithiasis, thiazide",
author = "Khashayar Sakhaee and Maalouf, {Naim M.} and Rajiv Kumar and Andreas Pasch and Moe, {Orson W.}",
year = "2011",
month = "2",
doi = "10.1038/ki.2010.473",
language = "English (US)",
volume = "79",
pages = "393--403",
journal = "Kidney International",
issn = "0085-2538",
publisher = "Nature Publishing Group",
number = "4",

}

TY - JOUR

T1 - Nephrolithiasis-associated bone disease

T2 - Pathogenesis and treatment options

AU - Sakhaee, Khashayar

AU - Maalouf, Naim M.

AU - Kumar, Rajiv

AU - Pasch, Andreas

AU - Moe, Orson W.

PY - 2011/2

Y1 - 2011/2

N2 - Nephrolithiasis remains a formidable health problem in the United States and worldwide. A very important but underaddressed area in nephrolithiasis is the accompanying bone disease. Epidemiologic studies have shown that osteoporotic fractures occur more frequently in patients with nephrolithiasis than in the general population. Decreased bone mineral density and defects in bone remodeling are commonly encountered in patients with calcium nephrolithiasis. The pathophysiologic connection of bone defects to kidney stones is unknown. Hypercalciuria and hypocitraturia are two important risk factors for stone disease, and treatments with thiazide diuretics and alkali, respectively, have been shown to be useful in preventing stone recurrence in small prospective trials. However, no studies have examined the efficacy of these agents or other therapies in preventing continued bone loss in calcium stone formers. This manuscript reviews the epidemiology, pathophysiology, and potential treatments of bone disease in patients with nephrolithiasis.

AB - Nephrolithiasis remains a formidable health problem in the United States and worldwide. A very important but underaddressed area in nephrolithiasis is the accompanying bone disease. Epidemiologic studies have shown that osteoporotic fractures occur more frequently in patients with nephrolithiasis than in the general population. Decreased bone mineral density and defects in bone remodeling are commonly encountered in patients with calcium nephrolithiasis. The pathophysiologic connection of bone defects to kidney stones is unknown. Hypercalciuria and hypocitraturia are two important risk factors for stone disease, and treatments with thiazide diuretics and alkali, respectively, have been shown to be useful in preventing stone recurrence in small prospective trials. However, no studies have examined the efficacy of these agents or other therapies in preventing continued bone loss in calcium stone formers. This manuscript reviews the epidemiology, pathophysiology, and potential treatments of bone disease in patients with nephrolithiasis.

KW - bone disease

KW - citrate

KW - kidney stone

KW - nephrolithiasis

KW - thiazide

UR - http://www.scopus.com/inward/record.url?scp=79551543869&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=79551543869&partnerID=8YFLogxK

U2 - 10.1038/ki.2010.473

DO - 10.1038/ki.2010.473

M3 - Article

VL - 79

SP - 393

EP - 403

JO - Kidney International

JF - Kidney International

SN - 0085-2538

IS - 4

ER -